EFPIA Urges Adoption of Anticounterfeiting Measure
ePT--the Electronic Newsletter of Pharmaceutical Technology
Brussels (May 30)-The European Federation of Pharmaceutical Industries and Associations (EFPIA) called for the pan-European and industry-wide adoption of 2-D barcode technology to combat the increase in counterfeit drugs in Europe.
Brussels (May 30)-The European Federation of Pharmaceutical Industries and Associations (EFPIA) called for the pan-European and industry-wide adoption of 2-D barcode technology to combat the increase in counterfeit drugs in Europe.
EFPIA proposed that every medicine pack in Europe have a 2-D data-matrix barcode printed on the packaging. The barcode would be encrypted and have a randomized number that is unique to each pack, making it difficult for counterfeiters to copy the barcodes and introduce counterfeit drugs into the legitimate supply chain. The code could be read by any handheld barcode scanner and would provide a chain of custody wherever it is scanned.
Counterfeit medicines have become a subject of increasing concern in Europe. The European Commission recently released figures that show a dramatic rise in the number of counterfeit medicines in the legitimate supply chain. The pharmaceutical industry is working to increase public awareness of the problem and come up with a feasible anticounterfeiting solution.
Benuvia Granted GMP Certification by Brazil National Health Surveillance Agency
March 14th 2025The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.
